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Abstract
Background Retinal degeneration is followed by significant
changes in the structure and function of photoreceptors in
humans and several genetic animal models. However, it is
not clear whether similar changes occur when the degen-
eration is induced pharmacologically. Therefore, our aim
was to investigate the influence of retinotoxic N-methyl-N-
nitrosourea (MNU) on the function, morphology and
underlying molecular pathways of programmed cell death.
Methods C57/BL6 mice were injected with different doses
of MNU, and function was determined by analysing
optokinetic reflex measurements and cued water maze
results at several time points post-injection. Morphometric
measurements were also taken from H&E-stained paraffin
eye sections. TUNEL-positive cells and caspase-3 and -6
were detected by immunohistochemistry. To assess the
molecular changes leading to cell death, qRT-PCR from
neurosensory retina mRNA was performed.
Results The application of MNU led to an instant decrease
in function and a delayed decrease in the thickness of the
retinal outer nuclear layer. These responses were observed
in the absence of any structural changes in the retinal
pigment epithelium. The degeneration of the photoreceptor
cell layer was highest with 60 mg/kg MNU. The assessment
of TUNEL-positive cells visualised cell death after treat-
ment, but no detectable caspase-3 activity was observed
concomitant with these changes. qRT-PCR revealed the
possible involvement of the inflammatory mediator caspase-1
and endoplasmic reticulum stress-mediated apoptosis by
caspase-12.
Conclusion MNU leads to the dose-dependent degeneration
of photoreceptor cells in mice by caspase-3-independent
pathways and is, therefore, a suitable model to study retinal
degeneration in an animal model.
Keywords Apoptosis . Caspases . N-methyl-N-nitrosourea .
Morphometry .Mouse . Programmed cell death . Retinal
degeneration . Visual function
Introduction
The term retinitis pigmentosa pertains to several
hereditary ocular diseases affecting photoreceptor cells,
which ultimately lead to severe visual impairment. So
far, over 100 different genes leading to retinal degen-
eration have been identified, providing a molecular
foundation for the significant variability seen in clinical
presentation and pathological progression [1]. In recent
years, many genetic mouse models for retinal degenera-
tion have been found or created artificially, all with a
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distinctive pathogenesis somewhat similar to those ob-
served clinically [2]. These models are beneficial in that
they facilitate the investigation of the roles of single gene
products in visual system function/pathology, but are not
without shortcomings. One major issue with respect to
genetic models of retinal degeneration relates to the time
course of the degeneration, which can be significant even
at birth. Functional measurements in newborn mice are
unfortunately limited, because the eyes open only 2 weeks
after birth. In some of the strains, one would miss the
period with the highest disease activity or, even worse,
detect an interference with the normal developmental
apoptosis in the retina. Furthermore, the genetically
triggered degeneration of the photoreceptors is sometimes
very fast, which leaves only a small time window for
experiments. A pharmacological model, in which onset
and progression rate could be varied with the concentra-
tion and application time point, could largely circumvent
these disadvantages.
The compound N-methyl-N-nitrosourea (MNU) is an
established experimental cancer-inducing agent. Several
publications have shown the development of both
benign and malignant tumours after MNU treatment
[3–5], with tumour development observed several months
post-exposure. In addition to this well-established role as
an experimental teratogen, MNU exposure also induces
the degeneration of the photoreceptor cells of rodent eyes
acutely following treatment but prior to tumour formation
[6]. The photoreceptor cells degenerate because of the
toxic effect of the compound, without damage in the
retinal pigment epithelium (RPE) cell layer [7], although
the exact pathogenesis remains poorly understood, which
has been an impediment to the broader acceptance of this
model to study retinal degeneration (e.g., retinitis
pigmentosa). To further evaluate this model, we used
two established methods to investigate the effect of MNU
on visual function. First, the cued water maze, a
modified version of the Morris water maze with a visible
platform, was used to test vision [8, 9]. Second, the
optokinetic reflex (OKR) measurement [10] was used to
quantify the visual acuity in non-anaesthetised animals.
Furthermore, using immunohistochemistry and relative
quantitative PCR we investigated putative molecular
pathways underlying the degenerative response of
photoreceptor cells. One major class of molecules
implicated in this response are caspases, which are
well-established mediators of apoptosis and other forms
of programmed cell death (PCD) in the retina [11]. In
this study, the involvement of several PCD pathways
including inflammatory caspases (e.g., caspase-1), initia-
tor caspases (e.g., caspase-2) and effector or executioner
caspases (e.g., caspase-3) are studied using the MNU
model of photoreceptor degeneration.
Materials and methods
Animals
C57BL/6 mice were used for this study (all male and 6–
8 weeks old) and were treated according to the regulations in
the ARVO Statement for the Use of Animals in Ophthalmic
and Vision Research. Mice received a single i.p. injection of
1% MNU in saline 0.5% (30, 45 or 60 mg/kg bodyweight;
Sigma-Aldrich, Buchs, Switzerland). Visual function tests
were conducted at days 3, 7, 14 and 21 post-injection (PI; n=
5). During the experiments, body weight and behaviour of the
animals were monitored to observe possible side-effects of
the substance. However, no refusal was observed. The
animals showed spontaneous activity like snuffling, grooming
or climbing, the fur was shiny and their eyes were open and
clear after MNU treatment.
Histology and autofluorescence
Eyes were enucleated from the mice after euthanasia at
days 1, 3, 7, 14 and 21 PI and fixed for at least 18 h with
4% PFA in PBS. The right eyes were embedded in paraffin,
and 7 μm sections were cut. Sagittally oriented central
sections of the optic nerve head (ONH) were used for
measurement purposes. The sections were stained with
hematoxylin and eosin (H&E) and analysed with Image-Pro
plus© (Media Cybernetics, Bethesda, MD, USA), and
individual measurements at six different locations in the
retina [400, 600 and 1200 μm superior (S1–S3) and inferior
(I1–I3) from the ONH] were taken. The thicknesses of the
outer nuclear layer (ONL) and inner nuclear layer (INL)
were calculated by measuring the layer area and dividing it
by the length of the area. The number of rows of
photoreceptor nuclei was counted at the same positions.
Statistical analysis was performed using Kruskal–Wallis
analysis on ranks and pairwise comparison with Tukey's
test in the SigmaStat 3.5 Software (Systat Software GmbH,
Erkrath, Germany).
To evaluate the changes in the RPE autofluorescence,
left eyes were processed for whole-eye flat mounts.
Thereby, connective and muscle tissue was removed and
an incision made at the ora serrata, followed by a
circumpolar cut. The anterior part of the eye, together with
the lens and sensory retina, were discarded, and the eyecup
washed in PBS and flattened onto a glass slide by making
four central cuts. The continuity of RPE fluorescence in
these flat mounts was studied on a confocal microscope (Leica
SP 2, Leica Microsystems, Heerbrugg SG, Switzerland) using
an Argon laser (wavelength 488 nm), and digital images were
acquired to compare control and MNU-treated specimens.
Finally, the area without autofluorescence was quantified
using imaging software (Image-Pro Plus; Media Cybernetics).
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TUNEL and immunohistochemistry
Paraffin tissue sections were also used for TUNEL staining
and immunohistochemistry. An in situ cell death detection kit,
TMR red (Roche Applied Science, Rotkreuz, Switzerland;
excitation wavelength 520–560 nm, emission maximum at
580 nm) was applied to detect TUNEL-positive cells within
the retina. Immunohistochemistry was performed with rabbit
anti-cleaved caspase-3 (Cell Signaling Technology, Danvers,
MA, USA; 1:200) or caspase-6 (Cell Signaling Technology;
1:100) in TBS with 0.1% Triton X-100, 1%BSA and 2% goat
serum, overnight at 4°C. Isotype control antibodies were used
as negative controls. Retina sections of prph2/rds mice
(postnatal day 14; kindly provided by Dr. Martin Reichel,
formerly Department of Ophthalmology, University of
Leipzig, Germany) served as a positive control [11]. To
visualise retinal structures in sections with degenerated
tissue, rhodopsin (mouse α-mouse opsin, Sigma-Aldrich;
1:10,000) was also stained. As secondary antibodies, goat α-
rabbit / mouse Alexa 488 nm / 594 nm (LuBioScience,
Luzern, Switzerland; 1:200/1:500 in TBS with 0.1% Triton
X-100 and 1% BSA, for 1 h at RT) were applied.
Cued water maze measurement
For the cued water maze, a circular pool (1.8 m in diameter,
0.7 m in height) filled with water (23°C), made opaque with
white non-toxic emulsion paint (Bahag AG, Mannheim,
Germany), was used. Because of the opacity, the white
platform (20 cm in diameter) placed inside the tank was
invisible. The location of the platform was identified with a
plastic cylinder (height 5 cm; radius 10 cm), which
extended about 1.5 cm above the water surface, on top of
the platform. The four release points for the mice were
arranged around the pool and named 1, 2, 3 and 4. Prior to
the tests, mice were familiarised with the pool and the
platform for 60 s. Afterwards, the mice were trained twice
with the platform and baseline measurements were recorded
before the application of MNU.
Swim track recording was performed with a high-
resolution camera (CCD-IRIA, Sony) placed above the
pool and connected to a computer. Every test session
including the baseline consisted of four trials, with the
platform as well as the release point changed after every
trial. Once a mouse reached the platform, it was allowed to
rest there for 15 s before it was removed from the pool.
Mice that failed to reach the platform were guided there
manually and also allowed to rest for 15 s. From the
recorded swim tracks, swim latency, path length and swim
speed were calculated using Ethovision (Noldus Informa-
tion Technology, Wageningen, The Netherlands). The
measurements were always taken in morning sessions, and
statistical analysis was performed using Kruskal–Wallis
analysis on ranks and pairwise comparison with Student–
Neumann–Keuls in the SigmaStat 3.5 software.
OKR measurement
The OptoMotry System from CerebralMechanics (Lethbridge,
AB, Canada) was used to measure the OKR. Avirtual cylinder
comprising a vertical sine wave grating was projected in 3D
coordinate space on computer monitors (17” LCD computer
monitors, Model 1703FP; Dell, Phoenix, AZ, USA) arranged
in a square around and projecting to the testing area, consisting
of a platform positioned 13 cm above a mirrored floor under a
likewise mirrored lid. To record the behaviour of the mice, a
video camera (DCR-HC26, Sony) was positioned directly
above the platform and connected to a computer, allowing live
video feedback. The computer was also used to project the
virtual cylinder on the monitors in a 3D coordinated space,
controlling the speed of rotation and geometry of the cylinder
and spatial frequency of the stimuli. The image on themonitors
was expanded by the mirrors on the floor and the ceiling,
thereby simulating the monitors as windows to a surrounding
3D world.
During testing the mice stood unrestrained on the
platform tracking the 3D pattern with a reflexive head
movement. The movements of the mice on the platform
were followed by the experimenter with a crosshair super-
imposed on the video image to centre the rotation of the
virtual cylinder with the x-y positional coordinates of the
crosshair at the mouse’s viewing position, maintaining the
pattern at a constant distance from the animal. Mice
normally stopped moving when a grating perceptible to
them was projected onto the cylinder wall and the cylinder
was rotated and began tracking the pattern with reflexive
head movements in concert with the rotation. The decision
of whether the mouse tracks the pattern or not was made by
the experimenter based on evident head movement against
the stationary arm of the crosshair. Animals that slipped or
jumped off the platform during the test trial were simply
returned to the platform and testing was continued. The
measurements were always taken in morning sessions, and
all animals were acclimated to the testing by placing them
on the platform for a few minutes without testing. Two
independent experimenters were blinded to treatment and
previous records whenever possible.
Tracking behaviour was assessed repeatedly for a few
seconds until unambiguous tracking was observed, to
reduce the possibility of adaptation to the stimulus and be
sure that each animal was capable of tracking when a
stimulus was present. The testing was initiated with a low
spatial grating and, using a staircase procedure, the spatial
frequency of the grating was increased randomly until the
animal no longer responded. The spatial frequency of the
test grating was changed repeatedly until the highest spatial
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frequency the mouse could track was identified as the
threshold. Statistical analysis was performed with a Krus-
kal–Wallis analysis on ranks and a pairwise comparison
using Student–Neumann–Keuls in the SigmaStat 3.5
software.
Quantitative polymerase chain reaction (qRT-PCR)
Mice were sacrificed 1, 3 and 7 days PI (45 mg/kg
bodyweight MNU), and enucleated eyes were immedi-
ately immersed in RNAlater (Qiagen, Hombrechtikon,
Switzerland). Neurosensory retina tissue was prepared by
an incision at the ora serrata followed by a circumpolar
cut. The anterior part of the eye as well as the lens was
discarded. The neurosensory retina was separated from
the eyecup and further processed to cDNA with the
μMACS™ RNA isolation kit and the μMACS™ one-
step cDNA kit (Miltenyi Biotech GmbH, Bergisch-
Gladbach, Germany) including a DNAse I (Ambion
Inc., Austin, TX, USA) treatment as recommended by
the manufacturer. All primers were quality controlled by
sequencing the template on a genetic analyser ABI
PRISM® 3100 (Applied Biosystems Inc., Foster City,
CA, USA). Primer sequences are depicted in Table 1.
The PCR samples were cleaned up and labelled with the
BigDye® Terminator V1.1 cycle sequencing kit (Applied
Biosystems Inc.). Reference gene analysis was performed
with a Mouse Endogenous Control Gene Panel (TATAA
Biocenter AB, Gothenburg, Sweden). The following two
reference genes were selected: phosphoglycerate kinase 1
(PGK) and peptidylpropyl isomerase A (PPIA).
Relative qRT-PCRwas performedwith iQ™ SYBR®Green
Supermix (Bio-Rad Laboratories, Reinach, Switzerland) on a
MyiQ™ single colour real-time PCR detection system
(Bio-Rad Laboratories). PCR samples were preheated to
95°C for 5 min and internal calibration was performed.
Fifty cycles were performed, each consisting of 30 s
denaturation at 95°C, a 30 s annealing at 58°C and a 30 s
extension at 72°C. To quantify the data, the following
calculations were performed: first, the mean of sample
duplicates, second, normalisation versus the two reference
genes (see above), and third, fold changes compared with the
controls. Separate control samples were prepared at each time
point. Statistical analysis was performed with GenEx (MultiD
Analyses AB, Gothenburg, Sweden) using an unpaired two-
tailed t-test with multiple testing correction.
Gene Alignement Prime sequence Size (bp)
PPIA Forward 5′-CAC CGT GTT CGA CAT CA-3′ 131
Reverse 5′-AGC CAA ATC CTT TCT CTC CAG-3′
PGk1 Forward 5′-AAT GTC GCT TTC CAA CAA GC-3′ 128
Reverse 5′-CAG CCT TGA TCC TTT GGT TG-3′
Calpain 1 Forward 5′-ACA TTT TAC GAG GGC ACC TG-3′ 139
Reverse 5′-ACT CCC GGT TGT CAT AGT CG-3′
Calpian 2 Forward 5′-CCC CAG TTC ATT ATT GGA GG-3′ 113
Reverse 5′-GCC AGG ATT TCC TCA TTC AA-3′
Calpain 10 Forward 5′-TCG GAC TCC TCG CTC TTT TA-3′ 135
Reverse 5′-CTT CAC CTG TCC CTC CCA T-3′
Cathepsin S Forward 5′-TCT AAT CGG ACA TTG CCT GAC A-3′ 105
Reverse 5′-CAC AGC ACT GAA AGC CCA ACA-3′
Atg5 Forward 5′-CAG CCG AAG CCT TTG CTC AAT GAA-3′ 122
Reverse 5′-ATT CTC CTG CCT AAG GTT CCA CCA-3′
Caspase 1 Forward 5′-CAC AGC TCT GGA GAT GGT GA-3′ 121
Reverse 5′-GGT CCC ACA TAT TCC CTC CT-3′
Caspase 7 Forward 5′-CCG AGT GCC CAC TTA TCT GT -3′ 91
Reverse 5′-ACC TGT CGC TTT GTC GAA GT-3′
Caspase 2 Forward 5′-CAC CCT CTT CAA GCT TTT GG-3′ 131
Reverse 5′-GTG CCA CTA CGC AGG AGT CT-3′
Caspase 8 Forward 5′-TTC TCC CTA CAG GGT CAT GC-3′ 125
Reverse 5′-GCA GGC TCA AGT CAT CTT CC-3′
Caspase 12 Forward 5′-CTG ACC CAG ATG CCC ACT AT-3′ 144
Reverse 5′-CCT GGG ATC TTG GAA TTT TCT-3′
Caspase 3 Forward 5′-ATG GGA GCA AGT CAG TGG AC-3′ 137
Reverse 5′-CGT ACC AGA GCG AGA TGA CA-3′
Caspase 6 Forward 5′-CCA GAC AGA CAA GCT GGA CA-3′ 143
Reverse 5′-TGT ACC AGG AGC CAT TCA CA-3′
Table 1 Primer sequences used
for qRT-PCR
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Results
Morphometric measurements
The lowest concentration of MNU (30 mg/kg) caused no
significant changes in the mouse retina (Fig. 1b) compared
to normal retinal morphology (Fig. 1a). However, damage
caused by higher MNU dose (45 mg/ kg) was visible at day
3 PI (Fig. 1c) and sustained over time (Fig. 1d). Retinal
structure was disturbed and swollen from day 3 PI, and the
thickness of the ONL was significantly decreased compared
with untreated control animals in the group that received
60 mg/kg MNU (Fig. 1e,f). Over time, the retina became
thinner, eventually leading to the almost complete loss of
the ONL in the 60 mg/kg group 1 week PI (Fig. 2a).
Additionally, we also counted the number of nuclei per row
in the ONL, and found comparable results (Fig. 2b). The
INL was unaffected except with the highest dose (60 mg/kg
MNU), where the INL also grew thinner (data not shown).
To investigate a possible spatial distribution of MNU-
induced changes, we also compared data from peripheral
and more central areas within the retina. Thereby, degen-
eration appeared more prominent in the periphery than at
the area of the ONH (Table 2 depicts data at day 21 PI). In
Fig. 1 Representative examples of H&E-stained paraffin sections
(7 μm). Control animals treated with 50 μl 0.9% NaCl i.p. display a
normal retina (a) with all cell layers fully preserved, including inner
and outer segments (IS+OS). After treatment with 30 mg/kg MNU, no
major changes in the retina were visible (b, day 14 PI). By
comparison, the application of 45 mg/kg MNU induced the disruption
of the outer segments at day 3 PI (c) and the ONL thickness was
decreased, a process that was sustained until day 7 PI where only one
row of nuclei was left (d). A similar outcome was seen with the
highest dose 60 mg/kg MNU (e: day 3 PI). At day 7 PI, there were no
cells in the ONL remaining, only cell debris (f). RPE cells were
unaffected by MNU, even with the highest dose used (see inserts in
panels a, e, f). However, in the first phase of the degeneration, at day 3
PI (e), they looked swollen and vacuolated, but afterwards, from day 7
PI, the monolayer appeared normal and recovered (f)
Fig. 2 Morphometric analysis of the H&E-stained paraffin sections after the
injection of MNU (black column=30 mg/kg, striped column=45 mg/kg,
dotted column=60 mg/kg MNU). The thickness of the ONL was calculated
by measuring the area of the ONL and dividing it by the length of the area
at six different locations in the retina (a). The number of rows of
photoreceptor nuclei was counted at the same positions (b). Horizontal lines
represent control values and significant differences were depicted by
asterisks (p value <0.05). Data are shown as mean±SD (n=5/group)
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contrast to the morphometric changes in the ONL, RPE
cells did not seem to be affected by MNU treatment in the
histological sections. Even though the RPE cells looked
swollen 3 days PI, their morphology appeared normal after
1 week (see inserts in Fig. 1a,e,f). Furthermore, RPE
autofluorescence was not significantly altered, with the area
void of RPE cells remaining unchanged over time (e.g.,
45 mg/ kg MNU vs control — d3 PI: 32.3×103 μm2 vs
35.4×103 μm2; d21 PI: 21.7×103 μm2 vs 20.9×103μm2).
Visual function
Cued water maze measurements did not reveal significant
differences between treated and untreated animals with
the lowest dose (30 mg/kg MNU) applied (data not
shown). With 45 mg/kg MNU, a significant difference in
path length (Fig. 3a) and latency (Fig. 3b) was detected 3
and 7 days PI. However, at later time points, as the number
of trials increased, swim distance and escape latency
decreased in both groups. The highest dose (60 mg/kg
MNU) showed a significant difference compared with the
control group in both parameters at all time points (data
not shown). No significant difference in swim speed could
be detected, indicating that MNU did not affect the
physical ability to swim. Furthermore, neither change in
body weight and behaviour nor any indication of tumour
development was found. Survival rates for all experimen-
tal animals also remained at 100% throughout the
experimental period.
OKR measurements recorded significant differences in
visual acuity in all treatment groups, confirming the OKR as
a more sensitive method than the cuedwater maze (Fig. 4). The
first group (30 mg/kg MNU) showed significantly reduced
visual acuity compared with the control group on day 1. The
threshold decreased further over time. By contrast, the 45 mg/kg
MNU group showed a significant decrease in OKR response
also beginning on day 1, but the OKR threshold remained stable
after a strong initial drop in visual acuity. Mice treated with
60 mg/kgMNU showed no optokinetic response from 1 day PI.
In contrast to the cued water maze method, the OKR
measurement showed no relearning effect, because optokinetic
behaviour is an involuntary movement of the eyes.
Immunohistochemistry
TUNEL staining showed no positive results in control
section (Fig. 5a) and after treatment with 30 mg/kg MNU
(Fig. 5b), but did so with 45 mg/kg MNU 3 and 7 days PI
(Fig. 5c, d). However, for the 60 mg/kg group the latest
positive immunostaining results obtained were 3 days PI
(Fig. 5e) because of significant cell loss, with few
assessable cells preserved in the ONL at later experimental
time points (Fig. 5f).
To have a deeper insight in the cell death pathway
induced by MNU, cleaved caspase-3 staining was per-
formed. No caspase-3-positive staining could be detected at
all time points and concentrations applied. A representative
example with 45 mg/kg MNU from day 7 is shown in Fig. 6a.
Treatment Location
I3 I2 I1 S1 S2 S3
Untreated 33.8±4.0 36.0±4.1 38.6±2.9 37.8±3.9 36.2±2.8 33.4±2.7
30 mg/kg 28.2±3.3 30.6±3.6 31.2±4.1 31.4±4.7 30.6±5.9 27.6±7.5
45 mg/kg 19.8±6.9 20.2±10.4 11.0±6.6 8.6±4.1 15.4±7.7 17.4±5.8
60 mg/kg 1.3±2.5 0±0 0±0 0±0 0±0 0±0
Table 2 ONL thickness in the
C57/BL6 mice after treatment
with different concentrations of
MNU at the different measure-
ment locations at day 21 (n=5;
mean±SD)
400, 600, 1200 μm superior
(S1-S3) and inferior (I1-I3) from
ONH
Fig. 3 Mean path length and latency measured in the cued water maze
after the application of 45 mg/kg MNU. The path length (a) and latency
(b) both declined over time because of a learning effect in both groups,
but the treated animals had significantly longer pathways and higher
latency at day 3 and 7 PI compared with the control (*, p value <0.05,
n=5/group). The swim speed was not significantly altered after the
application of MNU
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The untreated control was negative (Fig. 6b), whereas the
positive control (Fig. 6c), a retina section from a mouse with
the rds mutation that is known to induce caspase-3 cleavage,
was positive [11]. Furthermore, we stained caspase-6, as an
additional effector caspase in PCD. We observed a qualita-
tive decrease in caspase-6-positive cells over time and with
increasing MNU concentrations in the outer retina. Fig. 7
shows examples: from the untreated control group in 7a,
30 mg/kg at day 7 PI in 7b, 45 mg/kg at day 3 PI in 7c and
60 mg/kg at day 1 and day 3 PI in 7d and 7e respectively.
qRT-PCR
The reference gene analysis revealed three feasible candi-
dates: Phosphoglycerate kinase 1 (PGK), peptidylpropyl
isomerase cyclophilin A (PPIA), and hypoxanthine-guanine
phosphoribosyltransferase (HPRT). For logistical reasons,
only two of them, PPIA and PGK, were used.
To identify the pathways involved in retinal cell death, the
relative expression levels of several specific markers were
assessed: calpain-1, -2 and -10 (neurodegeneration), cathepsin
S (necrosis/lysosomal stress), Atg5 (autophagy), caspase-1
and -7 (inflammation), caspase-2, -8 and -12 (apoptosis/
initiator) and caspase-3 and -6 (apoptosis/execution). The
analysis at three time points after the injection of 45 mg/kg
MNU revealed changes in the gene expression of 50% of the
genes of interest: four genes were upregulated, two were
downregulated and six were not significantly altered com-
pared to the controls (Fig. 8). Table 3 contains the specific
values of the gene expression.
Discussion
These results show that an injection of MNU i.p. induces
cell death in the mouse retina, as already reported by other
Fig. 4 OKRmeasurements for visual acuity in the control group (circles)
and the 30 mg/kg (squares), 45 mg/kg (hexagons) and 60 mg/kg MNU
(triangles) treatment groups. All measurements showed significant
differences between treated and untreated animals (p value <0.05, n=
5/group) at all time points, except the baseline
Fig. 5 Paraffin sections stained with TUNEL (red, 580 nm) and DAPI
(blue). No positive cells were observed in the retinas of the control
mice treated with 50 μl 0.9% NaCl i.p. (a) as well as of the mice
treated with 30 mg/kg MNU (b). Three and 7 days after the
application of 45 mg/kg MNU, positive cells appeared in the ONL
of the retinas (c, d). Note that panel d shows no discernable ONL. The
remaining row of photoreceptor nuclei (see Fig. 1d) is directly adjacent
to the INL. 60 mg/kg MNU led to TUNEL-positive cells in the ONL on
day 3 PI (e), whereas a severe decrease in cell numbers up to day 7 PI
left no positive cells at this time point (f). GCL = ganglion cell layer
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groups [6, 7]. We showed that the damage in the ONL of
the retina increased with time and concentration by staining
histological sections at different time points. But compared
with other pharmacological compounds inducing retinal
injury, such as NaIO3 [9], the correlation is non-linear.
Although 30 mg/kg MNU is barely enough to induce
significant retinal pathology, 45 mg/kg MNU results in
severe damage, comparable to the highest dose used
(60 mg/kg). In addition, the most significant cellular
ablation was observed in the first 3 days PI. This has also
been shown by others [7]. Consistent with the temporal
course of this cellular loss, we found a high amount of
TUNEL-positive cells and an immediate decline in the visual
acuity, which remains more or less stable in the chronic phase
of retinal pathology. By contrast, decrease of retinal thickness
is delayed, most probably because of the deferred clearance of
cellular debris. Furthermore, our morphometric data indicate
that the peripheral retina is more prone to MNU-induced
damage. However, others have seen an apoptotic index of the
peripheral retina similar to those of the posterior pole [12]. As
the retina shows physiological differences in this regard,
conclusions should be drawn carefully.
The major contribution of this study is the investigation
of functional changes associated with this experimental
model of retinal degeneration. The use of OKR and cued
water maze has already proved useful in the past to monitor
the changes in visual function after the application of cell
toxic substances, showing a rather expeditious course of
degeneration. With the OKR, we were not able to measure
any visual acuity in the mice treated with 60 mg/kg MNU
beginning on day 1 PI. Furthermore, the same mice were
unable to find the platform in the water maze, corroborating
this acute loss of visual function following a single
injection of MNU. In contrast to the highest dose, we
could still measure the visual function in mice treated with
45 mg/kg MNU. Visual acuity in the OKR was already
diminished significantly at day 1 PI, followed by a new
surge of optokinetic response. The heavy drop of visual
acuity might represent a block in DNA repair because of
Fig. 6 Staining for cleaved caspase-3 (green) and opsin (red) with
DAPI nuclei staining (blue). Staining for cleaved caspase-3 was
negative for all concentrations applied and all time points. In the
section shown here as a representative example (45 mg/kg MNU, day
7 PI), only the red opsin staining in the ONL and the outer segments
as well as the blue nuclei were detectable (a). The same result was
seen in the control (b). As a positive control, rds mice (BL6
background), which are known to activate caspase-3, were used (c)
Fig. 7 Staining for caspase-6
(green) with DAPI nuclei staining
(blue). Staining for caspase-6 was
positive in control sections and
after 30 mg/kg MNU treatment in
the outer retina. In retina sections
from mice treated with higher
MNU concentrations, no caspase-
6 staining was found at any
investigated time point. Shown
here are representative examples
for different time points and MNU
concentrations (a control group, b
30 mg/kg day 7, c 45 mg/kg day
3, d/e 60 mg/kg day 1/day 3)
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accelerated poly(ADP-ribose) formation and energy depletion
[13, 14]. This effect could then be partly equated, and
recorded acuity increased minimally after the first onset.
However, vision remained significantly reduced during the
investigated time period. Furthermore, differences of visual
acuity between the 45 and 60 mg/kg MNU groups do not
correlate directly with the found changes at the structural
level in these groups. Areas with remaining intact photo-
receptors might be able to compensate functionally for lost
cells in the ONL. Therefore, it appears that 45 mg/kg MNU
lead to higher damage in morphology compared to measured
visual function, at least at the level of the optic nerve head.
This was not the case with the cued water maze, where
the mice reached the same values in path length and latency
as the control mice after an initial significant increase (day
3 and day 7 PI). This relearning effect has been described
by other groups as well [15, 16], and led to a diminished
sensitivity of this method. However, using the cued water
maze one can measure the significant decrease in the visual
function to different degrees. Histology confirmed the
functional outcome for low and high doses. The medium
dose of MNU, however, showed decreased but stable visual
acuity despite increasing damage to the retinal structure
over time. This might be because of the remaining
peripheral photoreceptors in other areas, since we performed
morphometric measurements at one level only.
TUNEL staining was positive in our experiments, indicat-
ing cell death after MNU treatment. However, this method is
not specific for apoptosis, but only a detection system for cells
with fragmented DNA that can be caused by many different
pathways. Therefore, we wanted to gain more insight into the
pathogenesis and mode of cell death induced. We chose
45 mg/kg MNU, because with a higher dose the degeneration
takes place too fast and with a lower dose there is not enough
damage to detect. Owing to the importance of the activation of
caspase-3 in apoptosis, we first stained for cleaved caspase-3
in our tissue sections. The negative results indicated a caspase-
3-independent pathway. By contrast, uncleaved caspase-6 was
downregulated at higher MNU concentrations over time. An
explanation for this effect could be caspase-6 activation by
cleavage, protein degradation, or the inhibition of caspase-6
synthesis. Nevertheless, the involvement of caspase-6 might
indicate an alternative apoptotic pathway, because this caspase
has been demonstrated to bring about cell death in the absence
of caspase-3 activity [17].
Additionally, we selected several genes of interest covering
a broad spectrum of cell death pathways to investigate
alternative PCD regulation after MNU via qRT-PCR. The
expression of caspase-12 was significantly upregulated at day
1 and 3 PI, earlier than most of the other genes. Therefore,
caspase-12, which is known to participate in endoplasmic
reticulum (ER) stress-mediated apoptosis [18–20], is presum-
ably involved in the early steps of cell death induction by
MNU. Caspase-8, known as a pro-apoptotic initiator caspase,
was upregulated at day 3 PI only. This observation is
significant, in that it can activate calpain-2 [21, 22], which
d1 d3 d7
Calpain 1 Neurodegeneration −1.8 (1.6) 1.5 (2.1) 1.3 (1.4)
Calpain 2 Neurodegeneration 1.8 (1.5) 2.0 (2.1) 1.8 (1.3)
Calpain 10 Neurodegeneration −1.8 (1.3) −1.1 (1.8) 1.5 (1.3)
Cathepsin S Necrosis/ Lysosomal stress −1.1 (1.2) 1.6 (1.4) 1.8 (2.5)
Atg5 Autophagy −1.0 (1.2) −1.1 (1.2) 1.3 (1.2)
Caspase 1 Inflammation 2.3 (1.6) 10.1 (1.1) 1.8 (1.4)
Caspase 7 Inflammation −1.9 (1.1) −2.2 (1.2) −1.7 (1.1)
Casapase 2 Apoptosis/ Initiator −1.8 (1.1) −2.2 (1.2) −1.4 (1.3)
Caspase 8 Apoptosis/ Initiator 3.5 (1.2) 2.8 (1.2) 1.2 (1.3)
Caspase 12 Apoptosis/ Initiator 2.2 (1.3) 3.8 (1.2) 2.7 (1.4)
Caspase 3 Apoptosis/ Execution 1.1 (1.4) −1.1 (1.1) 1.0 (1.4)
Caspase 6 Apoptosis/ Execution −1.2 (3.2) 1.3 (1.4) 2.6 (1.4)
Table 3 Mean fold change in
mRNA (±SD) measured by
qRT-PCR. Significant changes
are in bold
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Fig. 8 Fold change in mRNA measured by qRT-PCR. Every gene
is illustrated by three bars representing the time points analysed
(days 1, 3 and 7 PI). Significant differences are indicated by
asterisks [p value <0.05, n=5 for the treatment group (45 mg/kg),
n=3 for the control group]
was also upregulated at the same time point in our experi-
ments. Together they are thought to activate the effector
caspase-3 and induce apoptosis. These data support the
proposed role of calpain-2 in MNU-induced cell death as
suggested by others [23]. The third upregulated caspase,
caspase-1, is highly homologous to caspase-12 and a
mediator caspase for innate inflammation [24–26]. Caspase-
2, an initiator caspase activated by death receptors such as
Fas, was downregulated, indicating that the extrinsic pathway
of apoptosis is not involved [27]. As a member of the
classical apoptotic pathway, caspase-7 was also downregu-
lated. No significant regulation was found for Atg, a marker
for autophagy, caspase-3 and -6, both effector caspases [28],
and calpain-1 and -10, involved in calcium-induced cell death
and known to participate in many forms of neurodegeneration
[29]. Together with no detectable change in gene expression
of caspase-3, the downregulation of caspase-7 indicated that
the classical pathways are not switched on by MNU [28, 30].
This confirms the immunohistochemical results, where we
found no caspase-3 involvement. By contrast, the decrease of
uncleaved caspase-6 after MNU treatment in the staining
experiments could be explained by a lack of RNA
upregulation of the enzyme seen in PCR (see above).
The increase of cathepsin S expression on day 3 PI was
not significant. A significant upregulation of the expression
of this gene would have pointed to necrosis or apoptosis
induced by lysosomal stress, as indicated by others [31].
In summary, the results from immunohistochemistry and
gene expression analysis indicate that the caspase-3-
dependent apoptosis pathway is not triggered by MNU.
Therefore, other apoptotic pathways have to be involved in
MNU-induced photoreceptor degeneration. One candidate
might be caspase-8, regarded as the key initiator of death
receptor-mediated apoptosis [28]. The role of other cas-
pases might not be essential for inducing cell death via
MNU. Bax and Bcl-2 have been shown to be involved in
the process as well [12]. Our data also indicated that most
probably other pathways such as ER stress-mediated
apoptosis or inflammation were involved. Further inves-
tigations in this direction might lead to detailed insight into
cell death pathways in retinal degeneration, but this was not
the focus of the current study. Additionally, MNU provides
a suitable pharmacological model for specific photoreceptor
degeneration. By choosing the appropriate concentration,
one can influence the scale of damage and use functional
outcome measurements to quantify the efficiency of cell
replacement or neuroprotective therapies.
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